|
|
|
Summary
of 1995 CPCRA Posters and Presentations
| 2nd National Conference on Human Retroviruses and Related Infections, February 1995, Washington, DC |
Gibert C, Wentworth D. Cytomegalovirus (CMV) Disease and Mycobacterium Avium (MAC) Disease in HIV-infected Patients. Poster.
abstract
Neaton J. Considerations in Specifying the Duration of Followup of Antiretroviral Trials. Oral.
Neaton J. Can it Work? Does it Work? Differing Expectations for Clinical Trials. Arguments for Pragmatic Clinical Trials for Persons with HIV. Oral.
| HIV Infection in Women Conference, February 1995, Washington, DC |
Melnick SL, Sherer R, Hillman D, Neaton J. Rates of HIV Disease Progression (DP) and Mortality (MT) in Women and Men. Poster. CPCRA 003 ODB.
abstract
Brosgart C, Craig C, Hillman D, Louis T, Fisher E, Ramser JC, Alston B, Scott JW. Gender Differences in HIV Related CMV Disease Incidence. Poster. CPCRA 023 CMV.
abstract
El Sadr W, Brosgart C, Wentworth D, Neaton J. Characteristics of HIV Disease and its Treatment Among HIV Infected Women From Different Racial/Ethnic Groups. Poster.
abstract
Cargo SA, Khan D, Mandel N, Phillips R, Ragland K, Rowley CY, Staton B. Educational Newsletter for Patients Focusing on Women, HIV/AIDS, and Clinical Research. Poster.
abstract
Simon PM, Morse EV, Besch CL. Barriers to Compliance Among Women Co enrolled in a PCP Prophylaxis and Compliance Protocol. Poster.
abstract
| 16th Annual Meeting of the Society for Clinical Trials, April 1995, Seattle, WA |
Shen W, Hodges JS. Forecasting Enrollment Capacity in a Cooperative Clinical Trial Network. Poster.
abstract
Wentworth D, El Sadr W, Zurlinden J. A Data Collection System Designed to Facilitate Participation in Multiple Concurrent Clinical Trials. Poster.
abstract
Green L, Neaton J, Bartsch G, Capps L, Deyton LR, Friedland G, Krum E, Myers M, Perlman D, Price R, Rhame F, Sampson J, Schnittman S. A Clinical Events System with Committee Review for a Large Clinical Trials Network. Oral.
abstract
Matts J, Dain B, Launer C. A Graphical Assessment of the Potential Impact of Losses to Followup on the Validity of Study Results. Oral.
abstract
Myers M, Green L, Krum E, Schultz T, Svendsen K. A Data Management Tool for Tracking Clinical Endpoint Reviews. Printed.
abstract
| Lancet Conference on TB, September 1995, Washington, DC |
Telzak E, Chirgwin K, Howard S, Matts J, Perlman D, El Sadr W. A Prospective Study of Predictors for Multidrug Resistant Tuberculosis (MDRTB) Among HIV Infected Patients. Printed.
abstract
| 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 1995 |
Zahnow K, Hillman D, Matts J, Finley E, Gordin F. Tuberculosis (TB) Skin Test Conversion Rates Among Health Care Workers (HCWs) Providing HIV Care. Poster. CPCRA 018 TB/HCWs.
abstract
Gordin F, Nelson E, Matts J, Cohn D, El Sadr W. The Impact of Human Immunodeficiency Virus (HIV) Infection on Drug Resistance Tuberculosis (TB) in the United States (US). Poster. CPCRA 017 TB/Registry.
abstract
Brosgart C, Hillman D, Louis T, Alston B. A Randomized, Placebo-Controlled Trial of the Safety and Efficacy of Oral Ganciclovir for Prophylaxis of CMV Retinal and Gastrointestinal Mucosal Disease in HIV-infected Individuals with Severe Immunosuppression. Oral.
abstract
CPCRA 023, CMV. Gibert C, Launer C, Bartsch G, Muurahainen N, Abrams DI, Besch CL, Wheeler D. Body Weight and Percent Weight Change as Predictors of Mortality in HIV. Poster.
abstract
Perlman D, El-Sadr W, Nelson E, Heifets L, Telzak E, Chirgwin K, Salomon N, Matts J, Hafner R. Susceptibility to Levofloxacin of Clinical Mycobacterium tuberculosis Isolates from Patients in a Multicenter Treatment Study of HIV-related Tuberculosis. Poster.
abstract
CPCRA 019, TB Treatment. Wheeler D, Launer C, Bartsch G, Muurahainen N, Besch CL, Abrams D, Gibert C. Change in Body Weight (WT) as a Predictor of Opportunistic Complications (OC) in HIV. Poster.
abstract
| Infectious Diseases Society of America, October 1995 |
Perlman D, El-Sadr W, Nelson E, Matts J, Telzak E, Salomon N, Chirgwin K, Hafner R. Radiographic Presentations of HIV-Related Tuberculosis Vary by CD4+ Count. Poster. CPCRA 019, TB Treatment.
abstract
|
|
